OTC · RFCS
Healthcare · Medical - Devices
$0.00
Up+$0.00 (+0.00%)
Updated Aug 24, 2026, 4:52 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
RFCS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning RFCS.
RFCS research
Company profile and research snapshot.
Refocus Group, Inc., a medical device company, engages in the research and development of treatments for human vision disorders, primarily for presbyopia. The company develops VisAbility Micro-Insert System, an investigational medical device that is in clinical trials for use in the binocular presbyopic treatment. It serves patients and eye care professionals. The company was founded in 1994 and is based in Dallas, Texas.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
newsfilecorp.com · Oct 31, 2025
Vancouver, British Columbia--(Newsfile Corp. - October 31, 2025) - American Copper Development Corporation (CSE: ACDX) ("ACDX" or the "Company") announces a leadership transition. Effective immediately, Anthony Paterson has been appointed Chief Executive Officer and Director, with Jeremy Ross and Ali Pickett joining the Board.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RFCS.
No results
No recent SID articles mention RFCS.
